Industry Updates Friday – 2020 Virtual Conference

Representatives from biotech and pharma companies will provide updates on their drug development efforts in the DM field:

• Avidity Biosciences
• Ionis Pharmaceuticals
• Dyne Therapeutics
• NeuBase Therapeutics

About the presenters:

Kristina Bowyer
Ionis Pharmaceuticals
Vice President, Patient Advocacy

Art Levin, PhD
Avidity Biosciences
Chief Scientific Officer

Dietrich A. Stephan, PhD
NeuBase Therapeutics
Chief Executive Officer

Romesh Subramanian, PhD
Dyne Therapeutics
Chief Scientific Officer